Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • COVID-19

Pandemic costs not yet estimated

    • General Internal Medicine
    • Infectiology
    • News
    • Prevention and health care
    • RX
  • 2 minute read

The Corona pandemic still has us in its clutches – with immense implications for the health of the body and mind, as well as for healthcare costs. The Federal Council has adopted an initial report. However, more precise data are still lacking for an exact quantitative assessment.

The Federal Council was asked to study the financial impact of the Corona pandemic on health care stakeholders. This includes the healthcare costs incurred by the federal government, cantons and insurers as well as those insured under the mandatory health insurance scheme (OKP) as a result of the pandemic. In addition, the effects on the premiums and reserves of the insurers of the OKP will be considered. A first interim report has been prepared, which contains an initial, mainly qualitative overview of the pandemic-related health care costs per cost unit. Because the pandemic is still ongoing and due to the usual time delay for data collection and processing, reliable data are currently only available to a limited extent. Quantitative statements are therefore only possible to a limited extent. In 2020, CHF 428 million was spent on the procurement of medical supplies (including logistics) and CHF 190 million on the procurement of vaccines (including logistics). For 2021, CHF 1.2 billion is budgeted for the procurement of medical supplies and vaccinations. This amount is specifically earmarked for the procurement of Covid-19 vaccines. Federal spending in 2020 for bills already received was CHF 194 million. An additional CHF 2.4 billion has been budgeted for analyses in 2021. An average day of treatment for a Covid 19 patient in a hospital bed unit was estimated to cost between CHF 1556-1778; with intensive care in the ICU, the average day of treatment per patient cost between CHF 3556-4444. The cantons’ share is at least 55%. Accordingly, the estimated inpatient costs for the cantons for 2020 range between approximately CHF 284 and 335 million. However, care must be taken when dealing with this information. The figures given here are rough estimates and not exact values.

Because the pandemic is ongoing, much of the information and data needed to respond to the postulate will not be available until a much later date. The question of the healthcare costs caused by the pandemic can only be answered conclusively once the pandemic has ended and the necessary data have been collected and evaluated. At present, the uncertainties are too great to be able to estimate all the financial implications for the entire healthcare system. Another report is to follow by the end of 2022.

Source, “Impact of Covid 19 Pandemic on Healthcare Payers,” 04/21/2021. Available at: www.bag.admin.ch/bag/de/home.html

 

CARDIOVASC 2021; 20(4): 40 (published 1/12/21, ahead of print).
InFo NEUROLOGY & PSYCHIATRY 2021, 19(6): 40.

 

Autoren
  • Leoni Burggraf
Publikation
  • CARDIOVASC
Related Topics
  • CORONA
  • Costs
  • covid
Previous Article
  • Dementia

Clarification in practice

  • CME continuing education
  • Education
  • Geriatrics
  • Neurology
  • Psychiatry and psychotherapy
  • RX
  • Studies
View Post
Next Article
  • Wound Management

Successfully treat venous leg ulcer with compression therapy

  • Dermatology and venereology
  • Education
  • Endocrinology and Diabetology
  • Phlebology
  • RX
  • Traumatology and trauma surgery
View Post
You May Also Like
View Post
  • 3 min
  • Asthma in Adults: Bronchodilation and Anti-Inflammatory Therapy

Remodeling can be counteracted through a proactive treatment strategy

    • RX
    • Allergology and clinical immunology
    • Congress Reports
    • General Internal Medicine
    • Pneumology
    • Studies
View Post
  • 3 min
  • From symptom to diagnosis

Gynecomastia and Adipomastia

    • RX
    • Cases
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Gynecology
    • Radiology
    • Surgery
View Post
  • 7 min
  • Plastic surgery and reconstructive microsurgery for DFS

Functional limb preservation between infection control, vascular medicine and resurfacing

    • RX
    • Angiology
    • CME continuing education
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Geriatrics
    • Physical medicine and rehabilitation
    • Surgery
View Post
  • 12 min
  • SURPASS-CVOT

Tirzepatide versus Dulaglutide in T2D with ASCVD

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 6 min
  • Secondary prevention after ACS: individually optimized lipid management

Trend towards early combination therapy and new strategies for lowering Lp(a)

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Studies
View Post
  • 27 min
  • Pediatric Brain Tumors

Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls

    • RX
    • CME continuing education
    • Neurology
    • Oncology
    • Pediatrics
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 13 min
  • What the latest studies on the entire EF spectrum mean for clinical practice

Heart Failure – The 2026 Evidence Update

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • Studies
View Post
  • 5 min
  • Acute ischemic stroke

Alteplase and Tenecteplase Are on the Same Level

    • RX
    • Education
    • Emergency and intensive care medicine
    • Neurology
    • Pharmacology and toxicology
    • Studies
Landingpage Fachinfo Landingpage Button
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.